{"title":"默克公司诉惠氏公司案","authors":"","doi":"10.1093/rpc/rcac006","DOIUrl":null,"url":null,"abstract":"\n H1 Patents — European patents — Vaccines — Formulations — Use of surfactants — Revocation — Infringement — Validity — Construction — Person skilled in the art — Common general knowledge — Reliance on textbooks and scientific publications — Reliance on other vaccines containing surfactants — Whether claim limited to use in vaccines with identified serotypes only — Added matter — Novelty — Obviousness","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MERCK SHARP & DOHME LTD v WYETH LLC\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcac006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n H1 Patents — European patents — Vaccines — Formulations — Use of surfactants — Revocation — Infringement — Validity — Construction — Person skilled in the art — Common general knowledge — Reliance on textbooks and scientific publications — Reliance on other vaccines containing surfactants — Whether claim limited to use in vaccines with identified serotypes only — Added matter — Novelty — Obviousness\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcac006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcac006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
H1 Patents — European patents — Vaccines — Formulations — Use of surfactants — Revocation — Infringement — Validity — Construction — Person skilled in the art — Common general knowledge — Reliance on textbooks and scientific publications — Reliance on other vaccines containing surfactants — Whether claim limited to use in vaccines with identified serotypes only — Added matter — Novelty — Obviousness